Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 6/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10598528 | 0.76 | NAAA (0.61) | DUTNAAA | |
| SCHEMBL13539818 | 0.74 | NAAA (0.59) | DUTNAAA | |
| SCHEMBL2181554 | 0.64 | CRBN (0.54) | DUTALDH1A1LMNACA1CA2 | |
| SCHEMBL25367953 | 0.64 | NAAA (0.45) | DUTALDH1A1LMNANAAA | |
| SCHEMBL25430771 | 0.64 | GPR84 (0.44) | — | |
| Sebacic Acid SCHEMBL30166507 | 0.62 | TSHR (0.92) | ALDH1A1LMNA | |
| SCHEMBL31211775 | 0.62 | TSHR (0.92) | ALDH1A1LMNA | |
| Sebacic Acid SCHEMBL27937400 | 0.60 | TSHR (0.86) | ALDH1A1LMNA | |
| SCHEMBL25186232 | 0.59 | TSHR (1.00) | ALDH1A1LMNA | |
| Azelaic Acid SCHEMBL2724296 | 0.59 | TSHR (1.00) | ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11479534-B2 | Compound and use thereof in medicine | CHANGSHA HOOZ BIOSCIENCE AND TECHNOLOGY CO., LTD (CN) | 2022-10-25 | — | — | US | disclosed |
| US-20210061773-A1 | COMPOUND AND USE THEREOF IN MEDICINE | CHANGSHA HOOZ BIOSCIENCE AND TECHNOLOGY CO., LTD (CN) | 2021-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210061773-A1 | COMPOUND AND USE THEREOF IN MEDICINE | HDAC1, HDAC11, HDAC10 | DUT 2793/4885ALDH1A1 269/4885LMNA 4364/4885 |
| US-11479534-B2 | Compound and use thereof in medicine | HDAC1, HDAC11, HDAC10 | DUT 2793/4885ALDH1A1 269/4885LMNA 4364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.